›› 2020, Vol. 40 ›› Issue (12): 1067-1072.

• Basic Research • Previous Articles     Next Articles

Research on human amelobastoma cells inhibiting the osteogenic differentiation of hBMSCs

  

  • Received:2020-05-21 Revised:2020-06-28 Online:2020-12-28 Published:2020-12-22

Abstract: Abstract: Object: To explore the mechanism of ameloblastoma in inhibiting proliferation, osteogenic differentiation and autophagy level of human bone marrow derived mesenchymal stem cells (hBMSCs) to affect bone regeneration. Method: Human ameloblastoma cells (hAMCs) were isolated and identified. The conditional media was collected to culture the hBMSCs. CCK-8 kit was used to detect the hBMSC proliferation, while ALP staining, Alizarin Red staining and Western-blot were applied to investigate the osteogenic differentiation and autophagy status of the hBMSCs. Results: The osteogenic phenotype of hBMSCs were inhibited by hAMC-CM. The markers of osteogenesis and autophagy in hBMSCs were down-regulated, such as Runx2, Osx, ALP, OCN, OPN, Collagen I, ATG5, Beclin and LC3b. Conclusion: hAMCs could affect autophagy status of hBMSCs via their paracrine functions to inhibit osteogenesis.

Key words: hAMCs, bone marrow mesenchymal stem cells, bone regeneration, autophagy

CLC Number: